← Evidence map

ArticleFrontiers in immunology2022

Vitamin D metabolism pathway polymorphisms are associated with efficacy and safety in patients under anti-PD-1 inhibitor therapy.

Jianquan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36172344